<?xml version="1.0" encoding="UTF-8"?>
<p>Coronaviruses (CoVs) are enveloped viruses containing a single positive‐stranded RNA, and causing a wide array of respiratory, gastrointestinal, and neurological diseases in human hosts.
 <xref rid="minf202000028-bib-0001" ref-type="ref">1</xref>, 
 <xref rid="minf202000028-bib-0002" ref-type="ref">2</xref> It has been established that strains of CoVs were at the source of the 2002 severe acute respiratory syndrome (SARS) and 2012 middle east respiratory syndrome (MERS) epidemics.
 <xref rid="minf202000028-bib-0003" ref-type="ref">3</xref> In late December 2019, a novel CoV of SARS‐CoV‐2 was identified to be the cause of atypical pneumonia outbreak in Wuhan, China, named COVID‐19.
 <xref rid="minf202000028-bib-0004" ref-type="ref">4</xref> The rapidly increasing number of infected patients worldwide prompted the World Health Organization to declare a state of global health emergency to coordinate scientific and medical efforts to rapidly develop a cure for patients.
 <xref rid="minf202000028-bib-0005" ref-type="ref">5</xref> While drug repurposing may be a short‐term and non‐specific solution to treat COVID‐19 patients,
 <xref rid="minf202000028-bib-0006" ref-type="ref">6</xref> development of more targeted inhibitors is highly desirable.
</p>
